At the board meeting held on December 23, 2019, we resolved to take part of the stock acquisition rights of Immunity Research Inc. in connection with the financing by the capital increase of the company. Keima Ueno, the representative director of DOJIN CAPITAL serves as an outside director of the company.

Company Description

1. Company Name：Immunity Research Inc.
2. Headquarter：Goodoffice 6F, 2-10-1, Yurakucho, Chiyoda-ku, Tokyo, JAPAN
3. Representative：Masafumi Yasukochi, Representative Director
4. Business：Research on clinical effect determination of immune checkpoint inhibitors and development of clinical test kits
5. Founded：2017/5/15